Forest Laboratories Inc. (FRX) Stock Quote

Detailed Quote for Forest Laboratories Inc. (FRX)

After Hours: $ 38.1256

0.1456 (+0.38%)

Volume: 9 k

4:11 PM EDT May 20, 2013

close 52 Week Information

52Wk High

May 15, 2013

Close: 39.09

52Wk Low

August 1, 2012

Close: 31.28

Today

Last Price
37.98

Change $
0.55

Change %
1.43%

Tick

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
38.53

High
38.55

Low
37.915

Prev Close
38.53

Last Trade
05/20/13

Volume
792.69 k

52 Wk Hi
39.09

52 Wk Low
31.28

Market Cap
10.11 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
266,284,246

EPS (TTM)
-0.12

PE Ratio
N/A

close Market Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Forest Laboratories Inc. (FRX)

Sector News | Topic News

News for FRX

Fri, May 17, 2013

8:08 AM

Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference - Business Wire

Thu, May 16, 2013

8:00 AM

Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting - Business Wire

Tue, May 14, 2013

8:00 AM

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week\u00AE 2013 - Business Wire

Thu, May 09, 2013

6:00 AM

Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure - PR Newswire

6:00 AM

Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure - Business Wire

Thu, May 02, 2013

4:13 AM

Almirall and Forest Laboratories Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol Combination in COPD - Canada Newswire

3:48 AM

Almirall and Forest Laboratories Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol Combination in COPD - PR Newswire

Wed, May 01, 2013

2:17 PM

Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol combination in COPD - Business Wire

Tue, Apr 23, 2013

7:00 AM

Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Acquisition Amortization - Business Wire

Tue, Apr 16, 2013

5:46 AM

Almirall and Forest Laboratories Announce Positive Results of a Phase III Study for Aclidinium and Formoterol Combination in COPD - PR Newswire

2:30 AM

Almirall and Forest Laboratories Announce Positive Phase III Study Results for Aclidinium and Formoterol Combination in COPD - Business Wire

Mon, Apr 08, 2013

8:00 AM

Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope - PR Newswire

Tue, Apr 02, 2013

10:07 AM

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Fourth Quarter Earnings - Business Wire

Fri, Mar 08, 2013

8:00 AM

Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co. - PR Newswire

Fri, Feb 15, 2013

8:00 AM

Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition - PR Newswire

Tue, Feb 05, 2013

10:15 AM

From Perspectives to Struggles, Alzheimer's Family Caregivers Find Strength in Sharing - PR Newswire

Mon, Jan 14, 2013

8:01 AM

MAS, JNS, GGC and FRX Freshly Hit a New 52-Week High - Marketwired

Fri, Nov 09, 2012

10:14 AM

Equity Brief: Ratings Changes for November 9th: FLT, FLTX, FRX, GRPN, HCN, HD, HFC, HNT, IFNNY - Thomson Reuters ONE

Thu, Nov 01, 2012

9:38 AM

Financial Review on Healthcare Stocks Forest Laboratories Inc. and Endo Health Solutions Inc. -- Drug Manufacturers Focusing on Expansion and Litigation - Marketwired

Wed, Sep 26, 2012

9:46 AM

Where We Are Headed - New Outlook on Forest Laboratories, Inc. and Teva Pharmaceutical Industries Limited - Marketwired

More News for FRX >>

Tags for Forest Laboratories Inc.

Research stocks or mutual funds related to Forest Laboratories Inc. by keywords or tags. Find companies that have a similar focus to FRX. The keywords below have been associated to FRX by either user submission or electronic means.

life sciences market research pharmaceuticals research pharmaceutical branding pharmaceutical market generic pharmaceutical pharmaceutical investment pharmaceutical patents pharma strategy pharmaceutical research and development pharmaceutical manufacturing company pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company pharmaceutical cro pharma consulting pharmaceutical distributors pharmaceutical development pharmaceutical reports pharmaceutical magazine pharmaceutical consultant pharma product development pharmaceutical patent Drugs pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing frx contract pharmaceutical pharmaceutical consulting pharmaceutical medical packaging news pharmaceutical industry biotech contract pharmaceutical test pharmaceutical studies pharmaceutical strategy veterinary pharmaceutical patent research pharmaceutical advances pharmaceutical distributor pharmaceutical jobs pharmaceutical out licensing pharmaceutical business development pharmaceuticals license Healthcare medical and pharmaceutical packaging pharmaceutical contract research organizations pharmaceutical sector